Sigmedis, UAB - financials and debts

Company age: 17 y. 7 mo.

Update

Sigmedis - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 62,347 32,084 35,453 37,729 12,193 55,490 28,560 8,475
Profit before tax 5,584 510 9,969 14,669 -29,761 15,808 -8,270 -
Net profit 4,727 451 9,468 13,936 -29,761 15,808 -8,270 -22,793
Equity 75,056 76,079 85,546 99,482 69,722 85,529 77,260 54,467
Liabilities 91,059 110,400 193,772 181,571 173,309 140,370 162,475 150,028
Non-current assets 122,184 144,980 213,278 195,738 177,832 118,944 160,268 148,791
Current assets 75,707 64,127 79,519 89,646 65,199 106,955 79,467 55,704
Total assets 197,891 209,107 292,797 285,384 243,031 225,899 239,735 204,495
Taxes paid
STI taxes - - - - - 20,940 - -
Financial indicators
Revenue change y/y +58.4% -48.5% +10.5% +6.4% -67.7% +355.1% -48.5% -70.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 2.4% 0.2% 3.2% 4.9% -12.2% 7.0% -3.4% -11.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 6.3% 0.6% 11.1% 14.0% -42.7% 18.5% -10.7% -41.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 7.6% 1.4% 26.7% 36.9% -244.1% 28.5% -29.0% -268.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 9.0% 1.6% 28.1% 38.9% -244.1% 28.5% -29.0% -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.2 1.5 2.3 1.8 2.5 1.6 2.1 2.8
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 20,782 14,260 17,727 18,865 6,097 27,745 14,280 4,238

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Sigmedis - Social security debts

The amount of overdue SODRA debt for the company Sigmedis as of the last working day is: 0 €

From To Debt, €
2026-09-05 2026-09-14 0.24
2026-08-26 2026-09-02 0.24
2026-08-23 2026-08-23 0.24
2026-08-19 2026-08-19 0.24
2026-07-27 2026-08-10 0.24
2026-07-26 2026-07-26 0.11
2026-07-23 2026-07-25 0.24
2026-07-19 2026-07-22 0.11
2026-07-16 2026-07-17 0.11
2026-06-16 2026-07-07 0.11
2026-06-11 2026-06-14 0.11
2026-05-18 2026-06-08 0.11
2026-05-03 2026-05-14 0.11
2026-04-23 2026-04-29 0.11
2026-03-27 2026-03-27 248.58
2026-03-17 2026-03-18 248.58
2025-11-18 2025-12-14 0.35
2025-10-23 2025-11-13 0.35
2025-09-16 2025-09-23 24.94
2025-09-07 2025-09-14 24.94
2025-08-31 2025-09-03 24.94
2025-08-19 2025-08-29 24.94
2025-07-16 2025-07-31 24.94
2024-05-16 2024-06-13 0.04
2024-04-23 2024-05-14 0.04
2024-03-18 2024-04-14 0.71
2024-01-16 2024-03-14 0.71
2023-12-18 2024-01-11 0.71
2023-11-16 2023-12-13 0.71
2023-10-24 2023-11-13 0.71
2023-10-17 2023-10-23 0.60
2023-08-17 2023-10-15 0.60
2023-07-26 2023-08-03 0.60
2023-07-24 2023-07-25 0.61
2023-07-18 2023-07-23 0.52
2023-05-02 2023-07-16 0.52
2023-04-25 2023-04-28 0.52
2023-03-16 2023-03-23 181.13
2022-10-28 2022-11-13 0.63
2022-10-18 2022-10-27 0.47
2022-08-23 2022-10-13 0.47
2022-07-25 2022-08-15 0.47
2022-05-17 2022-05-24 141.59
2022-04-19 2022-04-20 107.61
2022-01-18 2022-01-20 88.46

Sigmedis - VMI tax arrears

From To Overdue, €
2026-03-08 2026-03-18 20.85

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Sigmedis, UAB (Private Limited Liability Company), company code 302309048, operates in logging. In 2025, revenue declined to €8.5K from €28.6K in 2024 and €55.5K in 2023, indicating a sharp two-year contraction in turnover. The business moved from a net profit of €15.8K in 2023 to a loss of €8.3K in 2024 and a deeper loss of €22.8K in 2025. The latest year shows profitability under significant pressure, with losses expanding faster than revenue. Balance sheet size remained relatively stable but weakened slightly, with total assets at €204.5K in 2025 versus €239.7K in 2024. Equity fell to €54.5K from €77.3K, while liabilities stood at €150.0K, leaving a leverage profile of 2.75 times debt to equity and an equity ratio of 26.6%. Asset turnover was low at 0.04x, reflecting limited use of assets to generate sales. Revenue per employee was €4.2K, while profit per employee was negative at €11.4K, consistent with the weak operating performance in 2025.